IMM-H004, a 3-piperazinylcoumarin compound derived from
coumarin, has been proved effective against CA1 cell loss and spatial learning impairments resulting from transient global
ischemia/reperfusion (TGCI/R), while the mechanism is still largely unknown. Here, we confirmed that treatment of rats with
IMM-H004 immediately after TGCI/R ameliorated delayed neuronal death (DND) in the CA1 of hippocampus and cortex. Further study suggested that
IMM-H004 contributed to the expression of antiapoptotic
protein survivin through the activation of PI3K-dependent
protein kinase B (PKB/Akt), which led to the phosphorylation of forkhead box O1 (FoxO1), then relieved the inhibiting effect on
survivin promoter. Additionally,
IMM-H004 also enhanced the expression of
hepatitis B X-interacting
protein (HBXIP), which formed a complex with
survivin to prevent the activation of
caspase death cascade, thereby halting apoptotic cell death. Finally, we injected a HBXIP
siRNA into hippocampus and performed microelectroporation before
ischemia/reperfusion, which abolished the protective effect of
IMM-H004. Further study revealed that HBXIP maintained the high expression of Akt and
survivin. Collectively, our findings demonstrated that DND after TGCI/R was alleviated by
IMM-H004 through promoting the formation of
survivin-HBXIP complex, which further emphasized the importance of endogenous
protein involved in self-repair after
stroke.